Why the study?
Does limited dose warfarin (≤ 5 mg/day) throughout pregnancy improve fetal and maternal safety outcomes in patients with mechanical heart valve prostheses?
Population
494 pregnancies in patients with a mechanical heart valve prosthesis across 11 studies.
Comparison
Limited dose warfarin throughout pregnancy, with… vs Higher INR target in a subgroup analysis.
Design
Meta-analysis
Follow-up
throughout pregnancy
Authors
Loading...
Supports lower INR targets with limited-dose warfarin in pregnant mechanical valve patients; extends meta-analytic safety data for optimized regimens.
Does limited dose warfarin (≤ 5 mg/day) throughout pregnancy improve fetal and maternal safety outcomes in patients with mechanical heart valve prostheses?
Limited dose warfarin (≤ 5 mg/day) throughout pregnancy in women with mechanical heart valves is associated with low rates of embryopathy and maternal complications, with even better fetal outcomes when targeting a lower-than-recommended INR of 1.5-2.5.
Hassouna et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: